The number of U.S. children who suffer seizures after swallowing prescription medications or illicit drugs has doubled in ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...

In response to a lawsuit, the FDA said it would reconsider its previous decision to remove tirzepatide, the active compound ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.

Providing coverage for weight-loss drugs such as Wegovy and Ozempic is forcing employers to make some critical decisions.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...

The 54 year old showed off his impressive frame in Men’s Health magazine last summer after shedding 200 pounds. He told the ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...